The 3rd Biennial Meeting of ASGO

December 13, 2013, Friday - Day 1

December 13, 2013, Friday - Day 1
The 3rd ASGO Opening: Luncheon Symposium: Eradication of Cervical Cancer from Earth: Global Approach
Cancer prevention through HPV vaccination in developing countries. Lynette A. Denny
Cancer screening via HPV testing and/or cytology. Murat Gultekin
Management of high grade cervical lesions and microinvasive cancer. Vesna Kesic
The 3rd ASGO Opening Plenary: Welcome from Japan
Presidential Lecture: Asian Society of Gynecologic Oncology: Whoweare, where We are going? Toshiharu Kamura
Invited Lecture: Mission of Federation of Asian Clinical Oncology(FACO). Masahiko Nishiyama
Educational Lecture :Toward individualization of radiation therapy by physical approach. Masahiro Hiraoka
Special Lecture : Genome-based tailoring for cancer therapy: A lesson from lung cancer. Hiroyuki Mano
The 3rd ASGO Evening Symposium (1) - Treatment of Advanced: Recurrent Ovarian Cancer: Future Perspective
Improving survival in women with ovarian cancer: Future directions. David M. Gershenson
Best combination of drugs for first second-line chemotherapy. Seiji Isonishi
Neoadjuvant chemotherapy in advanced ovarian cancer. Keiichi Fujiwara
How to select and perform surgery for recurrent ovarian cancer. Sang Yoon Park
Chemotherapy and best supportive care for recurrent patients. Chih-Long Chang
Roadmap for tailored medicine inovarian cancer treatment. David G. Huntsman
The 3rd ASGO Morning Lecture (1) - Treatment of Advanced Cervical Cancer: Update
Concurrent chemoradio therapy (CCRT) for locally advanced cervical cancer: What is next? Takafumi Toita
Chemotherapy for cervical cancer : Neoadjuvant and adjuvant setting. Nobuhiro Takeshima
Educational Lectureon Ovarian Cancer
Screening and early detection of ovarian cancer : Is it feasible? Barbara Goff
Fertility-sparing treatment for early ovarian cancer. Jeong-Won Lee
Treatment of platinum-resistant ovarian cancer. Koji Matsumoto
Updates on the management of advanced metastatic ovarian cancer. Lim Sheow Lei
Psychological support for patients with ovarian cancer. Vesna Kesic
Educational Lectureon Endometrial Cancer
Role of metabolic syndrome in endometrial cancer and its precancerous diseases. Xiaojun Chen
Pathology of endometrial cancer and its precursor. Annie NY Cheun
Atypical polypoid adenomyoma : Precursor of cancer? Tsunehisa Kaku
Treatment of high-intermediate risk endometrial cancer patients. Linus Chuang
Standard treatment of uterine carcinosarcoma(update). Chi-Heum Cho
The 3rd ASGO Luncheon Symposium (1) - Treatment of Stage IIB Cervical Cancer
Concurrent chemoradio therapy (CCRT) for Stage IIB disease: Where are we now? Kailash Narayan
Role of radical surgery instage IIB disease Treatment of Stage IIB disease. Mikio Mikami
The 3rd ASGO Asia-Oceania Symposium - Current Statuson Cervical Cancer in Our Country
Preventing cervical cancer in Australia: Still a little way to go. Michael A. Quin
Overview on cervical cancer control and prevention in Asian countries. Hextan YS Nga
How can we overcome adverse reactions in HPV vaccination in Japan? Etsuko Miyagi
Cervical cancer control in India: Strategy in urban vs rural areas. Neerja Bhatla
Current status of cervical cancer control in Thailand: Which screening method is best? Wisit Supakarapongkul
Cervical cancer control in multinational society: Challenge in Singapore. Sun Kuie Tay
The decreasing trend in cervical cancer in Taiwan: What is next? Choyng-Huey Lai
The 3rd ASGO Evening Symposium (2) - Molecular-Targeted Therapy for Gynecological Canceris Coming Soon
Molecular-targeted therapy in gynecologic oncology: Overview. Nicoletta Colombo
Anti-angiogenes is therapy for ovarian cancer: Moving beyond VEGF. Anil K. Sood
Perspective on molecular targeted therapy for endometrial cancer. Katsutoshi Oda
Is molecular-targeted therapy effective for uterine sarcomas? Chi-Mu Chuang
Selection of drugs against ovarian cancer based on gene expression profile. Noriomi Matsumura
Development of novel therapy for gynecological cancer. Jae-Hoon Kim

December 14, 2013, Saturday - Day 2

December 14, 2013, Saturday - Day 2
The 3rd ASGO Morning Lecture (2) - Ovarian Clear Cell Carcinoma: Update
Clinical and molecular features of ovarian clearcell carcinoma. Kentaro Nakayama
Moleculargenetics of ovarian clear cell carcinoma. David G. Huntsman
Workshop on Ovarian Cancer
Active genetic counseling with immunohistochemistry can elevate detection rate of BRCA mutation among ovarian carcinoma patients. Min Kyu Kim
Evaluation of Risk of Malignancy Index as atriage tool for ovarian cancer. Gregorius Tanamas
Comparison of CA-125,ultrasound, menopausal status and Risk of Malignancy Index(RMI)in pre-operative diagnosis of ovarian tumors. Arun Muthuvel Veluswamy
The management of peritoneal surface malignancies at the American University of Beirut Medical Center: Initial experience. Muhieddine AF Seoud
Disseminated endometroid adenocarcinoma of ovary in a 14 year old girl: A case report. Himali, P Ihalagama
Additional intraperitonealcisplatin/etoposide to first-line chemotherapy in advanced epithelial ovarian cancer: Interim analysis of a randomized phase II study. Rong Jiang
Pazopanib maintenance therapy in East Asian (EA) women with advanced epithelialovarian cancer (AEOC): Results of two clinical trials. Jae-Weon Kim
Clinicopathologic characteristics in patients with synchronous primary endometrial andovarian cancers: A review of 43 cases. Yuantao Liu
Comparison of survival out come between clear cell and non-clear cell types of epithelial ovarian cancer instage IA and IB. Yu-Jin Koo
Primary treatment and prognostic factors of carcinosarcoma of ovary, fallopian tube, and peritoneum: A Taiwanese Gynecologic Oncology Group study. Chien-Hsing Lu
Workshop on Endometrial Cancer
Diagnostic value of the conventional and liquid-based endometrial cytology in endometrial cancer. Yuko Sugiyama
Significance of endometrial cells in cervical cytology. Eun Jeong Yu
Usefulness of transcervical tumor resection in diagnosing myometrial invasion for young patients with endometrial cancer who received fertility-preserving progesterone therapy. Nobuyuki Susumu
Endometrial cancer risk of recurrence and post operative histopathological findings. Jasmine Iskandar
Feasibility and safety of laparoscopic surgery for obese Korean women with endometrial cancer: Long-term results at a single institution. Min-Hyun Baek
Analysis of prognostic parameter in endometrial cancer: Obesity as aprognostic indicator in endometrial cancer. Ranka Kanda
Pure uterine papillary serous cancer: Evaluation of survival and managements: A Taiwanese Gynecologic Oncology Group (TGOG) study. Chia-Yen Huang
Longterm survival analysis of clear cell type endometrial cancer: A retrospective multi-center study by Taiwanese Gynecologic Oncology Group (TGOG). Keng-fu Hsu
Raloxifene hydrochloride improves health care problems of patients who underwent surgeries for endometrial cancer: A multicenter clinical trial. Koji Nakamura
Efficacy of methotrexate chemoprophylaxis in preventing postmolar gestational trophoblastic disease among patients with high-risk hydatidiform mole: A randomized controlled trial. Jimmy A. Billod
The 3rd ASGO Luncheon Symposium (2) - Diagnosisand Treatment of Uterine Sarcomas.
An update on the pathology of uterine sarcomas. Charles Zaloudek
Clinical diagnosis and treatment for uterine sarcomas. Yoshio Yoshida
Round Table Discussion for Serous Ovarian Cancer (SOC).
Tubal origin of high-grade serous carcinoma: Do you believe? Steven G. Silverberg
What have we learned from The Cancer Genome Atlas. Anil K. Sood
Molecular mechanism for peritoneal dissemination of serous ovarian cancer. Chul Min Lee
Pathology of border line serous tumors and lowgrade serous ovarian cancer. Charles Zaloudek
Imaging diagnosis of low-grade SOC and serous border line tumor. Kaori Togashi
Contemporary management of low-grade serous ovarian cancer. David M. Gershenson
Round Table Discussion for High-Risk Endometrial Cancer.
Imaging of myometrial invasion of endometrial cancer. Dong Hoon Suh
"MELF pattern" of myoinvasion of low-grade endometrial adenocarcinoma. Yoshiki Mikami
How to manage endometrial cancer with deep myometrial invasion? Hidemichi Watari
Uterine serous papillarycarcinoma: Pathology and molecular aspects. Ayse Ayhan
Clinical management of uterine serous papillary carcinoma. John Chia Whay Kuang
Treatment of Stage IV Bendometrial cancer: A retrospective multi-institutional study of 426 patients in Japan. Takako Eto
The 3rd ASGO Luncheon Symposium (3) - Era of HPV DNA Testing for Cervical Cancer Screening
The importance of HPV-16/18 genotyping in ASCUS and cervical cancer screening. Sun Kuie Tay
The role of HPV tests in cervical cancer screening in Japan and Asia. Ryo Konno
Palliative Care for Women with Gynecological Cancer * Someparts in Japanese
Pain management in women with advanced cervical cancer. Lynette A. Denny
Assessment of quality of life in palliative care for women with gynecologic cancer. Akiko Sukegawa
Investigation of the prevalence of neuropathic pain in gynecologic cancer patientsand efficacy and safety of oxycodone for pain management (INGYCO) study in Japan. Akiko Tozawa
Management of Malignant Ascites in Gynecological Cancer
Intraperitoneal chemotherapy inepithelial ovarian cancer. Shoji Nagao
Efficacy and safety of CART (cell-free and concentrated ascites reinfusion therapy) in gynecological cancer patients. Yasuhisa Terao

December 15, 2013,Sunday - Day 3

December 15, 2013,Sunday - Day 3
The 3rd ASGO Morning Lecture (3) - Laparoscopic Surgery for Gynecological Cancer
Role of laparoscopy in cervical cancer surgery. Hiroyuki Kanao
Laparoscopic surgery for endometrial cancer. Kung-Liahng Wang
Educational Lectureon Gynecologic Cancer Surgery (1)
How to be less radical in early stage cervical cancer. Michael A. Quinn
Radical hysterectomy for cervical cancer in Thailand. Jatupol Srisomboon
Nerve-sparing radical hysterectomy in the treatment of early cervical cancer. Dae-Yeon Kim
Radical trachelectomy for early stage cervical cancer. Chi-An Chen
Surgery following neoadjuvant chemotherapy (NAC) for cervical cancer. Chunling Chen
Educational Lectureon Gynecologic Cancer Surgery (2)
Cytoreductive surgery for advanced ovarian cancer. Suk-Joon Chang
Pelvic & paraortic lymphadenectomy in ovarian cancer. Suresh Kumarasamy
Peritoneal stripping in ovarian cancer surgery. Ting-Chang Chang
Surgery after neoadjuvant chemotherapy in ovarianc ancer. Kazuyoshi Kato
Surgery and chemotherapy in germ cell tumor of ovarian cancer. Laila Nuranna
The 3rd ASGO Luncheon Symposium (4) - Robotoic Surgery for Cervical Cancer
Robotic radical hysterectomy: Principle and practice. Angelo Maggioni
Robotic radical hysterectomy: Training for beginners. Masaki Mandai
Educational Lectureon Gynecologic Cancer Surgery (3)
Abdominal radical trachelectomy from our ten year's experience. Takuma Fujii
Robotic radical trachelectomy in Korea. Jae Kwan Lee
Sentinel node detection in radical trachelectomy. Hiroaki Kobayashi
The 3rd ASGO Morning Lecture (4) - Gestational Trophoblastic Disease: Update
Clinical manifestations of early stage hydatidiform mole. Takashi Ohba
Chemotherapy for high-risk trophoblastic neoplasm. Elizabeth K. Jacinto
The 3rd ASGO Luncheon Symposium (5) - Laparoscopic Lymphadenectomy for Gynecological Cancer
Pelvic lymph adenectomy for endometrial cancer. Yoshito Terai
Laparoscopic paraaortic lymphadenectomy. Hiroshi Funamoto